ey0018.6-11 | Reviews with Clinical Impact for DSD Care | ESPEYB18
MK Herlin , MB Petersen , M Brannstrom
ey0018.13-4 | Diabetes | ESPEYB18
B Kaufmann , P Boulle , F Berthou , M Fournier , D Beran , I Ciglenecki , M Townsend , G Schmidt , M Shah , S Cristofani , P Cavailler , M Foti , L Scapozza
ey0019.4-2 | Important for clinical practice | ESPEYB19
V Thaker , B Carter , M Putman
ey0017.12-16 | Hyperlipidemia | ESPEYB17
M Orthofer , A Valsesia , R, et al. Magi
ey0017.15-8 | (1) | ESPEYB17
B Winzeler , N Cesana-Nigro , J Refardt , DR Vogt , C Imber , B Morin , M Popovic , M Steinmetz , CO Sailer , G Szinnai , I Chifu , M Fassnacht , M Christ-Crain
ey0016.3-14 | Graves’ Disease | ESPEYB16
F Azizi , M Takyar , E Madreseh , A Amouzegar
ey0016.8-13 | New Hope | ESPEYB16
M Doroszko , M Chrusciel , J Stelmaszewska , T Slezak , S Anisimowicz , U Plockinger , M Quinkler , M Bonomi , S Wolczynski , I Huhtaniemi , J Toppari , NA Rahman
ey0015.1-7 | Mechanism update | ESPEYB15
T Fu , M Towers , MA Placzek
ey0015.3-15 | Post-Fukushima thyroid cancer risk | ESPEYB15
G Steinhauser , M Chavez-Ortega , JW Vahlbruch
ey0015.10-14 | Comorbidities – short and long-term complications | ESPEYB15
LM Duca , B Wang , M Rewers , A Rewers